Stockreport

Immuneering Corporation (IMRX) Discusses Phase 2a Data Update For IMM-1-104 In First-Line Pancreatic Cancer (Transcript) [Seeking Alpha]

Immuneering Corporation - Class A  (IMRX) 
PDF Company Participants Benjamin Zeskind - Co-Founder, President, CEO & Director Conference Call Participants Laurence Watts Jay Olson - Oppenheimer & Co. Inc., Re [Read more]